Peginesatide Acetate Patent Expiration
Peginesatide Acetate is Used for managing anemia associated with chronic kidney disease. It was first introduced by Takeda Pharmaceuticals Usa Inc
Peginesatide Acetate Patents
Given below is the list of patents protecting Peginesatide Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Omontys | US7550433 | Erythropoietin receptor peptide formulations and uses | Jun 02, 2026 | Takeda Pharms Usa |
| Omontys | US7919461 | Erythropoietin receptor peptide formulations and uses | Jun 02, 2026 | Takeda Pharms Usa |
| Omontys Preservative Free | US7550433 | Erythropoietin receptor peptide formulations and uses | Jun 02, 2026 | Takeda Pharms Usa |
| Omontys Preservative Free | US7919461 | Erythropoietin receptor peptide formulations and uses | Jun 02, 2026 | Takeda Pharms Usa |
| Omontys | US7084245 | Peptides that bind to the erythropoietin receptor |
May 12, 2024
(Expired) | Takeda Pharms Usa |
| Omontys | US7414105 | Peptides that bind to the erythropoietin receptor |
May 12, 2024
(Expired) | Takeda Pharms Usa |
| Omontys | US7528104 | Peptides that bind to the erythropoietin receptor |
May 12, 2024
(Expired) | Takeda Pharms Usa |
| Omontys | US7919118 | Spacer moiety for poly (ethylene glycol) modified peptide based compounds |
May 12, 2024
(Expired) | Takeda Pharms Usa |
| Omontys Preservative Free | US7084245 | Peptides that bind to the erythropoietin receptor |
May 12, 2024
(Expired) | Takeda Pharms Usa |
| Omontys Preservative Free | US7414105 | Peptides that bind to the erythropoietin receptor |
May 12, 2024
(Expired) | Takeda Pharms Usa |
| Omontys Preservative Free | US7528104 | Peptides that bind to the erythropoietin receptor |
May 12, 2024
(Expired) | Takeda Pharms Usa |
| Omontys Preservative Free | US7919118 | Spacer moiety for poly (ethylene glycol) modified peptide based compounds |
May 12, 2024
(Expired) | Takeda Pharms Usa |
Peginesatide Acetate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List